Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Evaluation of cerebrovascular reserve in patients with cerebrovascular diseases using resting-state MRI: A feasibility study.

Taneja K, Lu H, Welch BG, Thomas BP, Pinho M, Lin D, Hillis AE, Liu P.

Magn Reson Imaging. 2019 Mar 5;59:46-52. doi: 10.1016/j.mri.2019.03.003. [Epub ahead of print]

PMID:
30849484
2.
3.

Cerebrovascular reactivity mapping without gas challenges.

Liu P, Li Y, Pinho M, Park DC, Welch BG, Lu H.

Neuroimage. 2017 Feb 1;146:320-326. doi: 10.1016/j.neuroimage.2016.11.054. Epub 2016 Nov 23.

4.

Clinical utility of cerebrovascular reactivity mapping in patients with low grade gliomas.

Pillai JJ, Zacá D.

World J Clin Oncol. 2011 Dec 10;2(12):397-403. doi: 10.5306/wjco.v2.i12.397.

5.

Vascular steal explains early paradoxical blood oxygen level-dependent cerebrovascular response in brain regions with delayed arterial transit times.

Poublanc J, Han JS, Mandell DM, Conklin J, Stainsby JA, Fisher JA, Mikulis DJ, Crawley AP.

Cerebrovasc Dis Extra. 2013 Apr 12;3(1):55-64. doi: 10.1159/000348841. eCollection 2013.

6.

Invalidation of fMRI experiments secondary to neurovascular uncoupling in patients with cerebrovascular disease.

Para AE, Sam K, Poublanc J, Fisher JA, Crawley AP, Mikulis DJ.

J Magn Reson Imaging. 2017 Nov;46(5):1448-1455. doi: 10.1002/jmri.25639. Epub 2017 Feb 2.

PMID:
28152241
7.

Measurement of Cerebrovascular Reactivity as Blood Oxygen Level-Dependent Magnetic Resonance Imaging Signal Response to a Hypercapnic Stimulus in Mechanically Ventilated Patients.

Venkatraghavan L, Poublanc J, Han JS, Sobczyk O, Rozen C, Sam K, Duffin J, Mikulis DJ, Fisher JA.

J Stroke Cerebrovasc Dis. 2018 Feb;27(2):301-308. doi: 10.1016/j.jstrokecerebrovasdis.2017.08.035. Epub 2017 Sep 28.

PMID:
28967593
8.

Prolonged Mean Transit Time Detected by Dynamic Susceptibility Contrast Magnetic Resonance Imaging Predicts Cerebrovascular Reserve Impairment in Patients with Moyamoya Disease.

Kawano T, Ohmori Y, Kaku Y, Muta D, Uekawa K, Nakagawa T, Amadatsu T, Kasamo D, Shiraishi S, Kitajima M, Kuratsu J.

Cerebrovasc Dis. 2016;42(1-2):131-8. doi: 10.1159/000445696. Epub 2016 Apr 19.

PMID:
27088711
9.

Quantitative mapping of cerebrovascular reactivity using resting-state BOLD fMRI: Validation in healthy adults.

Golestani AM, Wei LL, Chen JJ.

Neuroimage. 2016 Sep;138:147-163. doi: 10.1016/j.neuroimage.2016.05.025. Epub 2016 May 11.

10.

Mapping cerebrovascular reactivity using blood oxygen level-dependent MRI in Patients with arterial steno-occlusive disease: comparison with arterial spin labeling MRI.

Mandell DM, Han JS, Poublanc J, Crawley AP, Stainsby JA, Fisher JA, Mikulis DJ.

Stroke. 2008 Jul;39(7):2021-8. doi: 10.1161/STROKEAHA.107.506709. Epub 2008 May 1.

PMID:
18451352
11.

Staging Hemodynamic Failure With Blood Oxygen-Level-Dependent Functional Magnetic Resonance Imaging Cerebrovascular Reactivity: A Comparison Versus Gold Standard (15O-)H2O-Positron Emission Tomography.

Fierstra J, van Niftrik C, Warnock G, Wegener S, Piccirelli M, Pangalu A, Esposito G, Valavanis A, Buck A, Luft A, Bozinov O, Regli L.

Stroke. 2018 Mar;49(3):621-629. doi: 10.1161/STROKEAHA.117.020010. Epub 2018 Jan 25.

12.

Noninvasive method for mapping CVR in moyamoya disease using ASL-MRI.

Noguchi T, Kawashima M, Nishihara M, Egashira Y, Azama S, Irie H.

Eur J Radiol. 2015 Jun;84(6):1137-43. doi: 10.1016/j.ejrad.2015.03.011. Epub 2015 Mar 18.

PMID:
25816991
13.

Effect of delayed transit time on arterial spin labeling: correlation with dynamic susceptibility contrast perfusion magnetic resonance in moyamoya disease.

Yun TJ, Sohn CH, Han MH, Kang HS, Kim JE, Yoon BW, Paeng JC, Choi SH, Kim JH, Song IC, Chang KH.

Invest Radiol. 2013 Nov;48(11):795-802. doi: 10.1097/RLI.0b013e3182981137.

PMID:
23764569
14.

Vascular risk factor burden correlates with cerebrovascular reactivity but not resting state coactivation in the default mode network.

Tchistiakova E, Crane DE, Mikulis DJ, Anderson ND, Greenwood CE, Black SE, MacIntosh BJ.

J Magn Reson Imaging. 2015 Nov;42(5):1369-76. doi: 10.1002/jmri.24917. Epub 2015 Apr 17.

PMID:
25884110
15.

Relationships between hypercarbic reactivity, cerebral blood flow, and arterial circulation times in patients with moyamoya disease.

Donahue MJ, Ayad M, Moore R, van Osch M, Singer R, Clemmons P, Strother M.

J Magn Reson Imaging. 2013 Nov;38(5):1129-39. doi: 10.1002/jmri.24070. Epub 2013 Feb 25.

16.

Cerebrovascular reactivity measured with arterial spin labeling and blood oxygen level dependent techniques.

Zhou Y, Rodgers ZB, Kuo AH.

Magn Reson Imaging. 2015 Jun;33(5):566-76. doi: 10.1016/j.mri.2015.02.018. Epub 2015 Feb 20.

17.

Reduced CMRO₂ and cerebrovascular reserve in patients with severe intracranial arterial stenosis: a combined multiparametric qBOLD oxygenation and BOLD fMRI study.

Bouvier J, Detante O, Tahon F, Attye A, Perret T, Chechin D, Barbieux M, Boubagra K, Garambois K, Tropres I, Grand S, Barbier EL, Krainik A.

Hum Brain Mapp. 2015 Feb;36(2):695-706. doi: 10.1002/hbm.22657. Epub 2014 Oct 12.

PMID:
25307948
18.

Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.

Kuhn FP, Warnock G, Schweingruber T, Sommerauer M, Buck A, Khan N.

J Stroke Cerebrovasc Dis. 2015 May;24(5):965-71. doi: 10.1016/j.jstrokecerebrovasdis.2014.12.017. Epub 2015 Mar 23.

PMID:
25813061
19.
20.

Quantification of cerebrovascular reactivity by blood oxygen level-dependent MR imaging and correlation with conventional angiography in patients with Moyamoya disease.

Heyn C, Poublanc J, Crawley A, Mandell D, Han JS, Tymianski M, terBrugge K, Fisher JA, Mikulis DJ.

AJNR Am J Neuroradiol. 2010 May;31(5):862-7. doi: 10.3174/ajnr.A1922. Epub 2010 Jan 14.

Supplemental Content

Support Center